Metraipolis › archive › dc_4cee02ee1e04
The CTDP1 Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic Approaches — Europe PMC PMID:41515914
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41515914
- DOI
- 10.3390/ijms27010034
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T12:57:36.771Z
- SHA-256 of the archived text
1f06f8770a9b7861a6d89008faffa71aa1ecbeb78e233e38703515e6565f6539- Stable URL of this page
https://metraipolis.com/documento/dc_4cee02ee1e04
How to cite
The CTDP1 Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic Approaches — Europe PMC PMID:41515914 — Europe PMC (en), https://europepmc.org/article/MED/41515914 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cee02ee1e04 (Metraipolis archive dc_4cee02ee1e04, sha256 1f06f8770a9b7861a6d89008faffa71aa1ecbeb78e233e38703515e6565f6539)
BibTeX
@misc{dc4cee02ee1e04,
title = {The CTDP1 Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic Approaches — Europe PMC PMID:41515914},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41515914},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cee02ee1e04; sha256 1f06f8770a9b7861a6d89008faffa71aa1ecbeb78e233e38703515e6565f6539},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41515914. Agents can read the archived copy with the MCP tool read_document.